Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03650491 |
Title | A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Fortis Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco | California | 94143 | United States | Details | |
University of Colorado Cancer Center | Aurora | Colorado | 80045 | United States | Details | |
Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | United States | Details | |
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University | Baltimore | Maryland | 21231 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
Washington University in St. Louis-Siteman Cancer Center | Saint Louis | Missouri | 63310 | United States | Details | |
Icahn School of Medicine at Mt. Sinai | New York | New York | 10029 | United States | Details |